researchdrivelogo.jpg
Increasing Cases of Coronavirus Infection around the World to Propel the Growth of Global COVID-19 Diagnostics Market – Exclusive Report [410 Pages] By Research Dive
August 18, 2021 09:04 ET | Research Dive
New York, USA, Aug. 18, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global covid-19 diagnostics market is expected to generate a revenue of $65,750.1 million by...
5ef2af588104f70ce6d76d97_1.jpg
Global WholeHealth Partners Corp.'s (OTC: GWHP) Antibody IgG/IgM and Antigen Tests That They Offer Are Capable of Detecting the DELTA B.1.617.2, United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) of COVID 19 SARS 2
July 26, 2021 07:00 ET | Global WholeHealth Partners Corp.
SAN CLEMENTE, CA, July 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Global WholeHealth Partners Corp. (OTC: GWHP) offers one of the largest line of Covid-19 tests. Global WholeHealth Partners...
researchdrivelogo.jpg
Global COVID-19 Diagnostics Market Predicted to Garner Noteworthy Revenue of $65,750.1 Million by 2028 at a CAGR of 3.5% from 2021-2028 – Exclusive Report [410 Pages] By Research Dive
July 20, 2021 09:04 ET | Research Dive
New York, USA, July 20, 2021 (GLOBE NEWSWIRE) -- A recently published report by Research Dive states that the global COVID-19 diagnostics market is expected to observe an increase in revenue from...
FBI LOGO TM.png
COVID-19 Diagnostics Market Size 2021 | To Reach USD 9.20 Billion in 2028; Increasing R&D Activities to Launch Unique Therapies will Favor Growth: Fortune Business Insights™
July 12, 2021 07:14 ET | Fortune Business Insights
Pune, India, July 12, 2021 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market is set to gain momentum from the increasing research and development activities to create numerous compounds and...
Logo (3).png
Immunoassay Market Worth $46.5 Billion by 2028, Growing at a CAGR of 7.5% From 2021- Exclusive Report by Meticulous Research®
June 04, 2021 08:13 ET | Meticulous Market Research Pvt. Ltd.
Redding, California, June 04, 2021 (GLOBE NEWSWIRE) -- According to a new market research report “Immunoassay Market by Product & Solutions (Immunoassay Kits {ELISA, Rapid Tests}, Immunoassay...
FBI LOGO TM.png
COVID-19 Diagnostics Market Size 2021 | Is Projected to Reach USD 6.22 Billion by 2027, Exhibiting a CAGR of 2.7%
May 10, 2021 07:17 ET | Fortune Business Insights
Pune, India, May 10, 2021 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market size is projected to reach USD 6.22 billion by 2027, exhibiting a CAGR of 2.7% during the forecast period. The...
Axim-Sapphire_Logo_-04 (1).png
AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files for Approval for Use of Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations in Canada and the EU
May 05, 2021 08:12 ET | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, May 05, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological...
Logo (3).png
Point of Care Molecular Diagnostics Market to be Worth $2.32 billion by 2027- Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®
April 01, 2021 07:30 ET | Meticulous Market Research Pvt. Ltd.
London, April 01, 2021 (GLOBE NEWSWIRE) -- According to a new market research report “Point of Care Molecular Diagnostics Market by Product & Service (Assay, Analyzer, Software, Service),...
FBI LOGO TM.png
COVID-19 Diagnostics Market 2021 | Size to Hit USD 8.04 Billion With 2.7% CAGR by 2027
March 26, 2021 03:09 ET | Fortune Business Insights
Pune, India, March 26, 2021 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market size is projected to reach USD 8.04 billion by 2027, exhibiting a CAGR of 2.7% during the forecast period....
Axim-Sapphire_Logo_-04 (1).png
AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files Emergency Use Authorization With FDA for Use of Its Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations
March 24, 2021 09:00 ET | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, March 24, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting...